Dear Madam, Dear Sir,
as phoney and inferior drug quality proliferation advances globally with focus on developing countries (see video documentary here), more and more drug compounds are liable to counterfeiting and will require repetitive testing during post-marketing monitoring to ensure that only quality medicines reaches the patient.
The need for more affordable and fast medicines testing is met by the GPHF-Minilab field test kit for which a supplement with new test protocols for more antibacterial, antimalarial and antituberculosis medicines has been issued now extending the Minilab’s total TLC method inventory and reference standards to overall 52 drug compounds including their appropriate fixed-dose combination products. The list of Minilab reference standards has been extended accordingly but the overall background list of Minilab equipment and chemicals stays unchanged.
A demo version in English is shown here; French and Spanish copies will come soon. The new supplement can now be obtained through our logistic partner Technology Transfer Marburg. Method development has been supported by USP/USAID.
The GPHF-Minilab is a mini-laboratory developed for rapid drug quality verification in order to detect counterfeit medicines and protect public health and patient safety in developing countries.
Reports on Minilab use and fake medicines identified in- and outside project work are wellcome.
Yours sincerely
Richard W. O. Jähnke, PhD
Project Management
More TB and malaria medicines added to the GPHF-Minilab® field testing kit
Global Pharma Health Fund e.V. (GPHF) |